09/16/2014 - 11:55am

The Food and Drug Administration on Tuesday announced approval for Movantik (naloxegol), a treatment for opioid-induced constipation in adults.

09/16/2014 - 11:09am

Baxter International announced that the Food and Drug Adminsitration approved Rixubis [coagulation factor IX (recombinant)] for the treatment, control and prevention of bleeding episodes, as well as perioperative management, in children with hemophilia B. 

09/15/2014 - 9:30am

Bayer HealthCare on Monday launched Aleve PM, the first over-the-counter nighttime product with a safe sleep aid plus the 12-hour pain-relieving strength of Aleve.

09/11/2014 - 12:21pm

The Food and Drug Administration approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) as a chronic weight-management option. 

09/10/2014 - 9:38am

America’s biopharmaceutical research companies are currently developing 44 medicines and vaccines for HIV/AIDS treatment and prevention.

09/10/2014 - 8:47am

RAP Protein Gummies brought a protein gummy product to market Wednesday. 

09/09/2014 - 10:54am

AstraZeneca's once-weekly Bydureon (exenatide extended-release for injectable suspension) pen now is available in pharmacies across the United States, the company announced.

09/05/2014 - 1:11pm

Merck on Thursday announced that the Food and Drug Administration granted accelerated approval to Keytruda (pembrolizumab) for the treatment of patients with advanced melanoma.

09/05/2014 - 9:29am

Mylan on Friday announced that it has launched a generic version of Hoffmann-La Roche's Boniva injection.